Type III neuregulin 1 is required for multiple forms of excitatory synaptic plasticity of mouse cortico-amygdala circuits.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 3865493)

Published in J Neurosci on June 05, 2013

Authors

Li Jiang1, Jaime Emmetsberger, David A Talmage, Lorna W Role

Author Affiliations

1: Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, New York 11794, USA. Li.Jiang@stonybrook.edu

Articles cited by this

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry (2005) 9.23

Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet (2002) 7.40

Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron (2005) 7.28

Axonal neuregulin-1 regulates myelin sheath thickness. Science (2004) 6.09

Neuregulin-1 type III determines the ensheathment fate of axons. Neuron (2005) 4.19

Amygdala inhibitory circuits and the control of fear memory. Neuron (2009) 4.16

Fezl is required for the birth and specification of corticospinal motor neurons. Neuron (2005) 3.61

Tangential neuronal migration controls axon guidance: a role for neuregulin-1 in thalamocortical axon navigation. Cell (2006) 3.12

The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron (2007) 2.96

Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling. Nature (2010) 2.51

Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry (2006) 2.32

Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron (2008) 2.27

Cysteine-rich domain isoforms of the neuregulin-1 gene are required for maintenance of peripheral synapses. Neuron (2000) 2.11

The Fezf2-Ctip2 genetic pathway regulates the fate choice of subcortical projection neurons in the developing cerebral cortex. Proc Natl Acad Sci U S A (2008) 2.07

Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors. Nat Med (2011) 2.05

Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice. J Neurosci (2007) 1.94

Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses. J Neurosci (2005) 1.86

Back signaling by the Nrg-1 intracellular domain. J Cell Biol (2003) 1.85

Tbr1 and Fezf2 regulate alternate corticofugal neuronal identities during neocortical development. J Neurosci (2011) 1.81

Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. J Neurosci (2008) 1.80

Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. J Neurosci (2011) 1.72

Intramembranous valine linked to schizophrenia is required for neuregulin 1 regulation of the morphological development of cortical neurons. J Neurosci (2010) 1.68

Presynaptic type III neuregulin1-ErbB signaling targets {alpha}7 nicotinic acetylcholine receptors to axons. J Cell Biol (2008) 1.61

Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos. Nat Neurosci (2004) 1.61

ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation. Proc Natl Acad Sci U S A (2010) 1.59

Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7). Am J Med Genet (2001) 1.47

Maintenance of acetylcholine receptor number by neuregulins at the neuromuscular junction in vivo. Science (1997) 1.46

A cysteine-rich isoform of neuregulin controls the level of expression of neuronal nicotinic receptor channels during synaptogenesis. Neuron (1998) 1.44

Glutamate uptake determines pathway specificity of long-term potentiation in the neural circuitry of fear conditioning. Neuron (2004) 1.43

The nucleus basalis magnocellularis cholinergic system: one hundred years of progress. Neurobiol Learn Mem (1997) 1.38

Genetics of chromosome 15q13-q14 in schizophrenia. Biol Psychiatry (2006) 1.36

The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders. J Neurosci (2012) 1.34

Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. I. Central nervous system. Neuroscience (1998) 1.25

ErbB4 is a suppressor of long-term potentiation in the adult hippocampus. Neuroreport (2008) 1.22

Presynaptic type III neuregulin 1 is required for sustained enhancement of hippocampal transmission by nicotine and for axonal targeting of alpha7 nicotinic acetylcholine receptors. J Neurosci (2008) 1.10

An acute effect of neuregulin 1 beta to suppress alpha 7-containing nicotinic acetylcholine receptors in hippocampal interneurons. J Neurosci (2006) 1.09

Alpha7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1. Hum Mol Genet (2007) 1.04

Cholinergic projections from the basal forebrain to the basolateral amygdaloid complex: a combined retrograde fluorescent and immunohistochemical study. J Comp Neurol (1985) 1.03

Neuregulin-1 signals from the periphery regulate AMPA receptor sensitivity and expression in GABAergic interneurons in developing neocortex. J Neurosci (2011) 1.03

Neuron-glia signaling and the protection of axon function by Schwann cells. J Peripher Nerv Syst (2010) 0.97

Facilitation of cortico-amygdala synapses by nicotine: activity-dependent modulation of glutamatergic transmission. J Neurophysiol (2008) 0.95

Type III neuregulin 1 regulates pathfinding of sensory axons in the developing spinal cord and periphery. Development (2011) 0.90

Cholinergic innervation of pyramidal cells and parvalbumin-immunoreactive interneurons in the rat basolateral amygdala. J Comp Neurol (2011) 0.89

Neuregulins and neuronal plasticity: possible relevance in schizophrenia. Novartis Found Symp (2008) 0.86

Support for the involvement of the ERBB4 gene in schizophrenia: a genetic association analysis. Neurosci Lett (2010) 0.85

Type III Nrg1 back signaling enhances functional TRPV1 along sensory axons contributing to basal and inflammatory thermal pain sensation. PLoS One (2011) 0.83

Acute neuregulin-1 signaling influences AMPA receptor mediated responses in cultured cerebellar granule neurons. Brain Res Bull (2011) 0.82

Genetic association analysis of ERBB4 polymorphisms with the risk of schizophrenia and SPEM abnormality in a Korean population. Brain Res (2012) 0.81

Neuregulin links dopaminergic and glutamatergic neurotransmission to control hippocampal synaptic plasticity. Commun Integr Biol (2009) 0.80

Schizophrenia candidate gene ERBB4: covert routes of vulnerability to psychosis detected at the population level. Schizophr Bull (2011) 0.80

Articles by these authors

Tangential neuronal migration controls axon guidance: a role for neuregulin-1 in thalamocortical axon navigation. Cell (2006) 3.12

Back signaling by the Nrg-1 intracellular domain. J Cell Biol (2003) 1.85

Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. J Neurosci (2008) 1.80

Nicotinic receptor-mediated effects on appetite and food intake. J Neurobiol (2002) 1.79

Intramembranous valine linked to schizophrenia is required for neuregulin 1 regulation of the morphological development of cortical neurons. J Neurosci (2010) 1.68

Presynaptic type III neuregulin1-ErbB signaling targets {alpha}7 nicotinic acetylcholine receptors to axons. J Cell Biol (2008) 1.61

Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron (2005) 1.58

Coordinate release of ATP and GABA at in vitro synapses of lateral hypothalamic neurons. J Neurosci (2002) 1.15

Presynaptic type III neuregulin 1 is required for sustained enhancement of hippocampal transmission by nicotine and for axonal targeting of alpha7 nicotinic acetylcholine receptors. J Neurosci (2008) 1.10

Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits. Semin Cell Dev Biol (2009) 1.06

Requirement of nicotinic acetylcholine receptor subunit beta2 in the maintenance of spiral ganglion neurons during aging. J Neurosci (2005) 1.02

Cholinergic modulation of appetite-related synapses in mouse lateral hypothalamic slice. J Neurosci (2005) 0.99

Facilitation of cortico-amygdala synapses by nicotine: activity-dependent modulation of glutamatergic transmission. J Neurophysiol (2008) 0.95

Selective deletion of the alpha5 subunit differentially affects somatic-dendritic versus axonally targeted nicotinic ACh receptors in mouse. J Physiol (2004) 0.94

Neurobiology: new order for thought disorders. Nature (2007) 0.92

Cholinergic modulation of purinergic and GABAergic co-transmission at in vitro hypothalamic synapses. J Neurophysiol (2002) 0.91

Disrupted activity in the hippocampal-accumbens circuit of type III neuregulin 1 mutant mice. Neuropsychopharmacology (2010) 0.91

Type III neuregulin 1 regulates pathfinding of sensory axons in the developing spinal cord and periphery. Development (2011) 0.90

tPA-mediated generation of plasmin is catalyzed by the proteoglycan NG2. Glia (2008) 0.84

Type III Nrg1 back signaling enhances functional TRPV1 along sensory axons contributing to basal and inflammatory thermal pain sensation. PLoS One (2011) 0.83

Cholinergic circuits and signaling in the pathophysiology of schizophrenia. Int Rev Neurobiol (2007) 0.82

Presynaptic type III neuregulin1-ErbB signaling targets alpha7 nicotinic acetylcholine receptors to axons. J Gen Physiol (2008) 0.81

Loss of anti-proliferative effect of all-trans retinoic acid in advanced stage of breast carcinogenesis. Anticancer Res (2009) 0.81

Overnight fasting regulates inhibitory tone to cholinergic neurons of the dorsomedial nucleus of the hypothalamus. PLoS One (2013) 0.80

Optogenetic studies of nicotinic contributions to cholinergic signaling in the central nervous system. Rev Neurosci (2014) 0.78

Retinoids arrest breast cancer cell proliferation: retinoic acid selectively reduces the duration of receptor tyrosine kinase signaling. Exp Cell Res (2004) 0.76